1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Respiratory Therapy News DECEMBER 2014

Respiratory Therapy News DECEMBER 2014

  • December 2014
  • -
  • Espicom Business Intelligence
  • -
  • 8 pages

Industry Brief - BeyondSpring To Initiate Plinabulin Phase III Trial In NSCLC
Industry Brief - FDA Grants Fast Track Designation To Novavax' RSV F Vaccine
Industry Brief - FDA Grants QIDP Designation To Bayer's Amikacin Inhale/Ciprofloxacin DPI
Industry Brief - CHMP Issues Positive Opinion For BI's Nintedanib In IPF
Industry Brief - EC Approves BI's Vargatef For NSCLC After First-Line Chemotherapy
Industry Brief - Teva Launches Erlotinib In Canada
Industry Brief - Dosing Begins In OncoMed's Tarextumab Phase II Trial For SCLC
Industry Brief - Dynavax/AstraZeneca To Advance AZD1419 Into Phase IIa Asthma Study
Industry Brief - flutiform Now Available In Spain And Italy
Industry Brief - FDA Accepts AstraZeneca's NDA Filing For Iressa
Industry Brief - Lung Therapeutics' LTI-01 Gains FDA ODD For Empyema
Industry Brief - Basilea Launches Zevtera In Germany
Industry Brief - Kyorin Markets flutiform 120-Puff Version In Japan
Industry Brief - Pfizer Launches Ultibro Breezhaler In UK
Industry Brief - Actelion Submits EU MAA For Selexipag In PAH
Industry Brief - GSK Seeks European Approval For Extended Indication Of Volibris
Industry Brief - FDA Approves Cyramza For Second-Line mNSCLC

Table Of Contents

Respiratory Therapy News DECEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.